Cas No.: | 304481-72-9 |
Chemical Name: | Pkumdl-WQ-2101 |
Synonyms: | (E)-2,4-Dihydroxy-N'-(2-hydroxy-5-nitrobenzylidene)benzohydrazide;PKUMDL WQ 2101;2,4-dihydroxy-N'-(2-hydroxy-5-nitrobenzylidene)benzohydrazide;OC1=C(C(=O)N/N=C/C2=C(C=CC(=C2)[N+](=O)[O-])O)C=CC(=C1)O;Pkumdl-WQ-2101 |
SMILES: | O([H])C1C([H])=C([H])C(=C([H])C=1/C(/[H])=N\N([H])C(C1C([H])=C([H])C(=C([H])C=1O[H])O[H])=O)[N+](=O)[O-] |
Formula: | C14H11N3O6 |
M.Wt: | 317.2536 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | WQ-2101 (WQ2101, PKUMDL-WQ-2101) is a specific, allosteric inhibitor of PHGDH with IC50 of 34.8 uM (WT PHGDH), shows dramatically reduced potenecy for mutants R134A (IC50 =141 uM) and K57AT59A (IC50=128 uM); shows dose-dependent suppression effects on the cell viability at micromolar concentrations, with good selectivity for PHGDH amplified breast cancer cell lines (MDA-MB-468 and HCC70 IC50= 7.70 and 10.8 uM); selectively inhibit de novo serine synthesis in cancer cells, and reduce tumor growth in vivo. |